IDEAYA Biosciences Reports Third-Quarter 2026 Results and Business Update
IDEAYA Biosciences reported its third-quarter 2026 financial results and provided a business update. The available body says ESMO 2026 data collectively supports the potential of darovasertib to become a foundation, but the statement is truncated.